Home » As Pfizer's HIV Drug Selzentry Gains FDA Approval, Monogram Preps for Trofile Launch

As Pfizer's HIV Drug Selzentry Gains FDA Approval, Monogram Preps for Trofile Launch

Aug 08, 2007
Premium
This story was updated to include pricing information for Selzentry.
 
Language in the US Food and Drug Administration-approved labeling for Pfizer’s HIV drug Selzentry, which recommends doctors establish the tropism status of their patients prior to administering the drug, may help Monogram Biosciences garner reimbursement for its Trofile assay, Monogram officials said this week.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Cloud Ready

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

The Science and Policy Connection

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

The New Yeast

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

This Week in Cell

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.